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Abstract 18 
Deoxyribonucleases (DNases) are abundant among the pathogenic streptococci, with most species 19 
harbouring genes for at least one. Despite their prevalence, however, the role for these extracellular 20 
enzymes is still relatively unclear. The DNases of the Lancefield group A Streptococcus, S. pyogenes 21 
are the best characterised, with a total of eight DNase genes identified so far. Six are known to be 22 
associated with integrated prophages. Two are chromosomally encoded, and one of these is cell-wall 23 
anchored. Homologues of both prophage-associated and chromosomally encoded S. pyogenes 24 
DNases have been identified in other streptococcal species, as well as other unique DNases. A major 25 
role identified for streptococcal DNases appears to be in the destruction of extracellular traps 26 
produced by immune cells, such as neutrophils, to ensnare bacteria and kill them. These traps are 27 
composed primarily of DNA which can be degraded by the secreted and cell wall anchored 28 
streptococcal DNases. DNases can also reduce TLR-9 signalling to dampen the immune response and 29 
produce cytotoxic deoxyadenosine to limit phagocytosis. Upper respiratory tract infection models of 30 
S. pyogenes have identified a role for DNases in potentiating infection and transmission, possibly by 31 
limiting the immune response or through some other unknown mechanism. Streptococcal DNases 32 
may also be involved in interacting with other microbial communities through communication, 33 
bacterial killing and disruption of competitive biofilms, or control of their own biofilm production. The 34 
contribution of DNases to pathogenesis may therefore be wide ranging and extend beyond direct 35 
interference with the host immune response.    36 
Introduction  37 
A number of clinically significant eukaryotic and prokaryotic microorganisms produce 38 
deoxyribonucleases (DNases) as virulence factors. These include Gram-positive bacterial pathogens 39 
such as Staphylococcus aureus and streptococcal species such as Streptococcus pyogenes [1, 2]. Gram-40 
negative pathogens such as Helicobacter pylori and Shigella flexneri, in addition to members of the 41 
genera Salmonella and Yersinia, also implement these enzymes in a similar manner [3, 4]. Further, the 42 
opportunistic fungal pathogens Candida albicans and Cryptococcus neoformans and the malarial 43 
parasites of the genus Plasmodium are also known to utilise DNases in pathogenesis [5-7]. 44 
The genus Streptococcus comprises a multitude of obligate and opportunistic pathogens of both 45 
humans and animals [8]. A classification system identified by Rebecca Lancefield in the 1930s is still 46 
used to classify the beta-haemolytic streptococci based on their type specific carbohydrate antigen 47 
[8]. S. pyogenes, the Lancefield Group A Streptococcus (GAS) is a major human pathogen responsible 48 
for a diversity of clinical manifestations and considerable global disease burden exceeding 700 million 49 
infections per annum [9]. Clinical manifestations include superficial infections such as pharyngitis, 50 
non-bullous impetigo and scarlet fever in addition to potentially lethal invasive manifestations such 51 
as streptococcal toxic shock syndrome, necrotising fasciitis and puerperal sepsis [10]. Furthermore, S. 52 
pyogenes is associated with serious post-infectious sequelae, notably post-streptococcal 53 
glomerulonephritis and rheumatic fever [11]. Streptococcus agalactiae, the Lancefield group B 54 
Streptococcus (GBS) is another major human pathogen and, although present as a commensal in the 55 
gastrointestinal and genitourinary tract, it is a leading cause of neonatal morbidity and mortality 56 
worldwide, often associated with neonatal meningitis, pneumonia and sepsis [12]. Streptococcus 57 
dysgalactiae sbsp. equisimilis (SDSE) can carry the Lancefield group C or G antigens and has only 58 
relatively recently been recognised as a major human pathogen, increasing in incidence and 59 
prevalence [13]. The spectrum of symptoms associated with SDSE infection are similar to those 60 
observed with S. pyogenes, indeed the two species share many virulence factors and significant DNA 61 
sequence similarity [13]. Other Lancefield group C streptococci include Streptococcus equi subsp. equi 62 
(hereafter referred to as S. equi) and S. equi subsp. zooepidemicus (hereafter referred to as S. 63 
zooepidemicus). S. equi is almost exclusively a pathogen of horses and is believed to be descended 64 
from an ancestral strain of S. zooepidemicus, which will readily colonise and infect humans in addition 65 
to a vast spectrum of domestic and livestock animals. Both species share in excess of 80% DNA 66 
sequence similarity with S. pyogenes [14]. 67 
The ability for Lancefield streptococci to cause a wide range of disease may be due to an extensive 68 
arsenal of virulence factors. Some of these factors, which include DNases, are associated with mobile 69 
genetic elements and can transmit between strains and even species. The function of DNases during 70 
pathogenesis is still relatively unclear and the potential for DNases to be virulence factors has only 71 
recently been explored.    72 
DNase history & nomenclature 73 
Historically, it was believed that S. pyogenes produced only four DNases and these were serologically 74 
classified as DNase A, DNase B, DNase C and DNase D. Anti-DNase B titres have been used as a 75 
serological biomarker of streptococcal infection and post-streptococcal immune sequalae since at 76 
least the 1970s [15, 16]. However, the identity of DNase B would not be truly known for over a decade 77 
when it was demonstrated that the chromosomally encoded DNase spdB or mitogenic factor (mf; then 78 
thought to be a streptococcal superantigen) was in fact DNase B [17]. It would be many years 79 
subsequent to the initial use of DNase B in the clinical laboratory before it was established that these 80 
enzymes could contribute to the pathogenesis of S. pyogenes [2]. DNase C is now known to be Spd3, 81 
and DNase D has been identified as Sda2 (SdaD2) [2], however, the identity of DNase A in the original 82 
serological system is not currently known. 83 
Since their discovery, the classification, nomenclature and role of the DNases found in streptococci 84 
has been a confusing topic. With advances in molecular biology and the application of whole genome 85 
sequencing, it is now apparent that a number of variants exist for the majority of DNases and there is 86 
homology between DNases of different streptococcal species.  87 
Genetic identification and classification of streptococcal DNases 88 
DNases of the Lancefield group A Streptococcus 89 
The DNases of group A Streptococcus are by far the best characterised and currently eight have been 90 
identified; spnA, spdB, sda1, sda2, spd1, spd3, spd4 and sdn. Both spnA and spdB are encoded on the 91 
chromosome and have been shown to be common to all S. pyogenes isolates tested, existing as 92 
different alleles related to the emm genotype of the isolate [18, 19]. We confirmed the presence of 93 
both spnA and spdB in all available completed S. pyogenes genomes (NCBI, n=54) representing 25 94 
different emm genotypes. SpnA is the only S. pyogenes DNase to be identified that is cell wall anchored 95 
via an LPXTG motif [19].  96 
The other six S. pyogenes DNases are associated with prophages or prophage-like elements (Table 1).  97 
S. pyogenes has a close evolutionary relationship with temperate bacteriophage as most strains are 98 
polylysogenised, and prophage and prophage-like-elements account for ~10% of the S. pyogenes 99 
genome [20, 21]. Bacteriophages are transmissible between hosts, carrying genes for bacterial 100 
virulence factors; the streptococcal superantigens, DNases and a secreted phospholipase. Different 101 
bacteriophages may carry the same virulence factor and each factor may exist as a different allele, as 102 
has been shown for the streptococcal superantigens [22]. By mining the 54 available genomes of S. 103 
pyogenes we identified that at least two different DNA sequence alleles exist for each of the six 104 
prophage associated DNases (Table 1). The most prolific prophage-associated DNase genes were spd1 105 
and spd3.  The other four prophage-associated DNase genes were restricted to isolates belonging to 106 
only 2-5 different emm genotypes, which may be reflective of host-specificity or functionality of the 107 
associated prophage. Twelve isolates did not carry any prophage-associated DNases and they 108 
belonged to the emm genotypes emm44, 59, 71, 82, 83, 89 and 101.  Although other emm89 isolates 109 
did carry prophage-associated DNases, two emm89 isolates (H293 and MGAS23530) have been shown 110 
not to have any prophage elements integrated into their chromosomes, and therefore only carry 111 
chromosomal DNase genes [23, 24].  112 
DNases of other streptococci 113 
Literature search and BLAST analyses identified DNases in other streptococcal species that are similar 114 
to those found in S. pyogenes.  Despite the prevalence of spd1 and spd3 among S. pyogenes isolates, 115 
we only identified three potential homologues of either of these genes (Figure 1). Homologues of spd1 116 
were identified by BLAST analysis (sharing A?90% identity over 75% or more of the sequence length) in 117 
isolates of S. iniae and S. porcinus, pathogens of fish and swine respectively, although they may also 118 
cause disease in humans. A third gene, similar to spd1 was identified in S. zooepidemicus MGCS1056, 119 
and is one of three inferred DNases in this genome termed sdzA (the spd1 homologue), sdzB and sdzD 120 
[25]. The gene sdzA was unique to MGCS1056 but the other two DNases were identified in the other 121 
three S. zooepidemicus genomes and the two genomes of the closely related equine pathogen S. equi. 122 
Alleles of the sdzD gene cluster with sda genes of S. pyogenes and SDSE, suggesting they are 123 
homologous.  Although in S. pyogenes, sda is associated with prophages, no such elements were 124 
identified associated with the sda-like genes of S. zooepidemicus [25], S. equi or SDSE. This was also 125 
the case for the third DNase gene of S. zooepidemicus and S. equi, sdzB, although it shares some 126 
similarity to the S. pyogenes chromosomally encoded spdB as well as the prophage associated spd4. 127 
Recently, two further DNases were identified in S. zooepidemicus that are cell wall anchored, termed 128 
ENuc and 5Nuc [26]. The enuc alleles identified in both S. zooepidemicus and S. equi clustered with 129 
other identified cell surface anchored DNases (Figure 1) that include spnA-like alleles from SDSE.  The 130 
SDSE spnA-like alleles all have a cell wall anchor motif, except spnA.5 carried by the SDSE strain 131 
GGS_124, which has a truncation mutation resulting in the loss of the far C-terminal region including 132 
the LPXTG anchor motif. Other cell surface anchored DNases that have been identified include the S. 133 
sanguinis cell wall anchored nuclease, SWAN and the S. suis SsnA. S. suis does not have a Lancefield 134 
antigen and is a pathogen of swine, but can cause severe zoonotic infection in humans.  SsnA of S. suis 135 
has been previously identified as a functional DNase [27, 28] along with EndAsuis, although EndAsuis 136 
is membrane anchored and shows homology to endA of S. pneumoniae which may play a role in 137 
competence [29].  The gene endAsuis did not show any homology to other streptococcal DNases 138 
analysed (Figure 1) although similar DNases with a role in competence may exist in other streptococcal 139 
species.  The nucA gene of S. agalactiae also appeared unrelated to any other identified streptococcal 140 
DNases, but has confirmed DNase activity [30]. It seems likely that other DNases exist in S. agalactiae 141 
but have yet to be identified.   142 
We did identify two prophage-associated DNases genes in SDSE.  One was in strain GGS_124 and 143 
associated with a prophage element that shares ~90% identity to prophage 315.3 from S. pyogenes 144 
emm3 genome MGAS315 [31]. Although in S. pyogenes, the prophage 315.3 is associated with the 145 
DNase spd4, the gene found in GGS_124 (SDSE167_1285, SDSE sdn) is 100% identical to a different 146 
prophage-associated S. pyogenes DNase, sdn.5 (Figure 1). Another SDSE strain, 167 also has a 147 
prophage-like element associated with a DNase gene [32].  The prophage is most closely related to a 148 
prophage-element found in emm1 NCTC8198 S. pyogenes, although this prophage is not associated 149 
with any virulence factors, the prophage element in the SDSE strain 167 is associated with an sda-like 150 
gene (SDEG_1103, SDSE sda2). However, in this strain, the gene carries a mutation that would truncate 151 
the protein. These findings suggest an exchange of prophages and associated virulence factors 152 
between S. pyogenes and SDSE. 153 
 154 
The Role of DNases 155 
Immune evasion 156 
Originally it was thought that DNases facilitated dissemination of streptococci through tissue planes 157 
in the human host by liquefying purulent exudate produced during infection [33]. It has also been 158 
speculated that in reducing the viscosity of the microenvironment, DNases expedite transmission of 159 
progeny phage particles between bacterial hosts, potentially conferring a selection advantage to both 160 
bacteriophage and bacterium [34]. Although this may still be the case, a recently described role for 161 
DNases is in the evasive strategy implemented by S. pyogenes to prevent neutrophil activation and 162 
degradation of neutrophil extracellular traps (NETs) (Figure 2) [35]. NETs are composed of chromatin, 163 
histones, proteolytic enzymes and other peptides, and produced by neutrophils on degranulation 164 
whereupon they bind to invading microorganisms by charge interaction [36]. Once entrapped, 165 
secreted cationic antimicrobial peptides attack the offending agent and neutralise virulence factors. 166 
Similar extracellular trap structures have been described in association with mast cells [37] and 167 
eosinophils [38], all of which can be degraded by DNases [39].  168 
By secreting DNases, such as Sda1, S. pyogenes is able to escape these bactericidal traps by degrading 169 
their chromatin backbone, thus surviving and spreading (Figure 2) [2, 35]. The ENuc and 5Nuc DNases 170 
of S. zooepidemicus also have the capacity to degrade NETs, both synergistically and alone, and 171 
enabled S. zooepidemicus to spread systemically in a murine model of infection [26]. The S. 172 
agalacatiae DNase NucA is also able to degrade NETs and its loss results in reduced virulence [30]. 173 
Cell wall anchored DNases have also been associated with NET degradation. The first description of a 174 
cell wall located DNase was the discovery of SsnA of S. suis [40]. S. pyogenes, further to secreting 175 
extracellular DNases, is also able to implement the cell wall anchored DNase SpnA to escape these 176 
traps [41]. The SWAN (Sanguinis cell wall anchored nuclease) of S. sanguinis, an opportunistic 177 
periodontal pathogen, has been shown to degrade NETs [42]. S. pneumoniae also produces a cell wall 178 
located nuclease, EndA, which is capable of degrading NETs [43] and a homologue of this enzyme, 179 
EndAsuis, can be found in S. suis. EndAsuis is reported to increase survival in NETs and is produced in 180 
addition to the aforementioned secreted nuclease [29]. Although it is unclear why streptococci might 181 
implement both cell-wall anchored and secreted DNases, they may provide necessary localised DNase 182 
activity in the immediate environment as well as more wide-spread activity [44]. S. pyogenes remained 183 
attenuated following deletion of the cell-wall anchored DNase SpnA, despite complementation with a 184 
secreted form of the enzyme [44]. SpnA may also have an additional role in pathogenesis that is not 185 
related to its enzymatic activity [44] and this may well extend to other streptococcal cell wall anchored 186 
DNases. 187 
Another method by which S. pyogenes is able to evade innate immunity is by degrading its own nucleic 188 
acids. Indeed, depolymerisation of bacterial DNA by DNases has been shown to prevent killing of S. 189 
pyogenes by reducing TLR-9 signalling and subsequent recognition of un-methylated CpG-rich DNA by 190 
macrophages [45]. The ENuc and 5Nuc DNases of S. zooepidemicus too have a dual action against the 191 
ŝŶŶĂƚĞŝŵŵƵŶĞƐǇƐƚĞŵ ?ŽƚŚŶƵĐůĞĂƐĞƐĚĞŐƌĂĚĞĞǆƚƌĂĐĞůůƵůĂƌƚƌĂƉƐďƵƚĂůƐŽƉŽƐƐĞƐƐ ? ?-nucleotidase 192 
activity and produce cytotoxic deoxyadenosine as a substrate, that impedes phagocytosis by 193 
macrophages [26]. A similar mechanism was also identified in S. pyogenes whereby a cell wall 194 
ĂŶĐŚŽƌĞĚ  ? ? ŶƵĐůĞŽƚŝĚĂƐĞ  ?^ ?Ŷ ? ĂĐƚĞĚ ƐǇŶĞƌŐŝƐƚŝĐĂůůǇ ǁŝƚŚƚŚĞ EĂƐĞ ^ƉŶ ƚŽ ĐůĞĂǀĞ EdƐ ĂŶĚ195 
generate the cytotoxic deoxyadenosine [46]. S5Na and SpnA are closely related to 5Nuc and ENuc of 196 
S. zooepidemicus, respectively (Figure 1) ?KƚŚĞƌƐƚƌĞƉƚŽĐŽĐĐĂůƐƉĞĐŝĞƐĂůƐŽĞǆƉƌĞƐƐ  ? ?ŶƵĐůĞŽƚŝĚĂƐĞƐ197 
and so similar mechanisms may exist for DNase synergy.  198 
Nutrient scavenging 199 
Elimination of DNA during infection may also have an indirect impact on pathogenesis, serving more 200 
than one purpose. For certain strains of S. pyogenes, nucleic acid derivatives are essential for growth. 201 
Indeed, efforts to standardise a laboratory method for sulphonamide sensitivity testing in the 1940s 202 
were hindered by this necessity [47]. Scavenging nucleic acids during infection or colonisation by 203 
implementing may therefore provide nutrients during both colonisation and infection. In addition, 204 
extracellular trap formation by neutrophils and mast cells ultimately leads to death of these 205 
phagocytes [39], and could provide further nutrients for the bacteria. This may also explain why S. 206 
pyogenes and other streptococci possess both secreted and cell-wall- anchored DNases, to retain 207 
DNase activity close to the bacterium for nutrition. 208 
Role of DNases during infection 209 
Experimental infection data obtained using a genotype emm1 strain with three DNases revealed that 210 
sequential inactivation of these genes, most importantly SdaD2, significantly impeded the capacity of 211 
the strain to establish pharyngeal infection in cynomolgus macaques [2]. Similarly, the acquisition of 212 
the Spd1 DNase by ST15 emm3 S. pyogenes was associated with increased nasal and airborne shedding 213 
in a murine nasopharyngeal infection model [48]. While not inherently more invasive, nor more lethal, 214 
the emm3 strains that had acquired Spd1 were found to be overrepresented in an upsurge of disease, 215 
and their emergence was coincident with a dramatic but transient spike in invasive emm3 disease in 216 
the United Kingdom [49]. The exact role DNase play during upper-respiratory tract infection has yet 217 
to be elucidated but these findings support the potential for DNases to contribute directly to infection. 218 
DNases have also been shown to contribute to the disease progression in murine skin and soft tissue 219 
infections [2,19,35] and the Galleria mellonella model of invasive disease [46], which may be due to 220 
their role in preventing NET-mediated killing as well as some other as yet un-identified role [46].  221 
Bacterial competition and communication 222 
Spd1 is also reported to have ribonuclease (RNase) activity [50]. A number of secreted eukaryotic 223 
RNases are known to be bactericidal; human RNases, such as the eosinophil cationic protein (also 224 
known as RNase 3) and the keratinocyte-derived RNase 7 have been shown to play an important role 225 
in innate immunity and defence against both Gram-positive and Gram-negative pathogens, by 226 
attacking the bacterial cell wall [51-53]. It may be the case, therefore, that the duality of some of the 227 
streptococcal DNases in their ability to also degrade RNA, may serve a similar offensive purpose. 228 
Microbial RNases have also been reported to have the capacity to damage eukaryotic cells both 229 
directly and indirectly of their ribonucleolytic activity, targeting various cellular components, leading 230 
to altered gene expression, cellular dysfunction and cell death [54].  231 
The contact-dependent growth inhibition (CDI) toxin of Yersinia kristensenii was recently identified as 232 
a novel bacterial RNase of the RNase A superfamily with a key role in bacterial competition and growth 233 
[55]. The RNase activity of streptococcal DNases may therefore also serve to mediate cell-cell 234 
interactions within and between bacterial species, coordinating microbial communities such as those 235 
observed in non-sterile sites and biofilm.  236 
It is also possible that these enzymes may be used by streptococci to compete with commensal 237 
microorganisms in non-sterile sites, such as in the nasopharynx or on the skin. Indeed, nucleic acids 238 
are a fundamental component of many microbial biofilms [56], and streptococcal DNases may be able 239 
to effectively eliminate biofilms formed by other bacteria or regulate the formation of its own biofilm.  240 
The EndA nuclease of S. pneumoniae plays a role in immune evasion, virulence and competence [43, 241 
57]. EndA degrades double-stranded DNA to single-stranded DNA during transformation for the 242 
purposes of uptake and recombination [57, 58]. Although no such mechanism has been described in 243 
S. pyogenes, it is possible that streptococcal DNases could reduce the potential for competing bacterial 244 
cells in the environment to be transformed by degrading extracellular DNA. 245 
Summary 246 
The prevalence of DNases suggests an important role in the biology of many streptococci, particularly 247 
S. pyogenes, with at least two being found in all strains tested. With the increased use of whole 248 
genome sequencing it may be that more DNases are identified and it will be important to maintain a 249 
consistent classification system across streptococcal species, similar to that proposed for the 250 
streptococcal superantigens [22]. 251 
It has been demonstrated experimentally that acquisition of prophage ?associated DNases does not 252 
necessarily increase the virulence of a strain, and the genetic background of the bacterial host may 253 
play a role [59]. Although this could also be dependent on the types of virulence assays used and the 254 
sensitivity of both in-vitro and in-vivo disease models which are required to build a more complete 255 
picture of how DNases function. Indeed, DNase production has been shown previously to require 256 
interaction with eukaryotic cells or induction by other external triggers [34].  257 
Both chromosomally-encoded and prophage-associated DNases have also been shown to be under 258 
the control of the extensive regulatory systems used by streptococci. This includes the control of 259 
virulence system (CovR/S or CsrR/S), which negatively regulates sdaD2 but positively regulates spdB 260 
in M1 strains [60] and Rgg, which negatively controls spdB and spd3 [61]. Other regulators such as 261 
PerR, Ihk/Irr and CodY have also been shown to influence expression of DNases [62-64]. Further work 262 
is required to fully understand the complex regulation of DNase expression, which could also be 263 
influenced by genotype and associated prophage.    264 
Interestingly, Walker et al demonstrated that sda1 (sdaD2) expression during disease is essential for 265 
emm1 strains and places a selective pressure upon CovR/S to mutate, not only to de-repress sda1 266 
expression but to down-regulate the protease SpeB which degrades Sda1 [65]. Sda1 can therefore 267 
influence the infection potential of isolates not only through direct means of protection against NETs, 268 
but also by indirectly promoting the development ŽĨ ‘ŚǇƉĞƌ-ǀŝƌƵůĞŶƚ ?ŽǀZ ?^ŵƵƚĂŶƚƐƚƌĂŝŶƐ ?  269 
The contribution of DNases to bacterial colonisation and infection may be extensive. The main focus 270 
of DNase research so far has been on the destruction of NETs, however there are other potential roles 271 
for DNases that may facilitate infection and warrant further research. 272 
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Table 1.  Prophage-associated DNases in S. pyogenes and their alleles. 453 
Gene Allele* Isolate Locus 
sda1 sda1.1 MGAS8232 (M18) spyM18_1746 
 sda1.2 MGAS10394 (M6), JRS4 (M6) M6_Spy1339, SPYJRS4_1267 
sda2 sda2.1 
(sdaD2) 
MGAS5005 (M1), A20 (M1), M1_476 
(M1), HKU360 (M12), MGAS2096 
(M12) 
M5005_Spy1415, A20_1463, 
M1GAS476_1494, SpyOHK_02660, 
MGAS2096_Spy1441 
 sda2.2 MGAS9429 (M12) MGAS9429_Spy1417 
spd1 
 
spd1.1 
 
SF370 (M1), MGAS10270 (M2), 
MGAS10750 (M4), MEW427 (M4), 
Manfredo (M5), MGAS9429 (M12), 
MGAS2096 (M12), HKU360 (M12), 
HKU488 (M12), MGAS8232 (M18), 
M23ND (M23), STAB120304 (M75), 
STAB14018 (M75), NGAS743 (M87), 
JMUB1235 (M89), MGAS27061 (M89), 
MGAS11027 (M89), NGAS322 (M114) 
 
SPy0712, MGAS10270_Spy0598, 
MGAS10750_Spy0622, AWM58_02815, 
SpyM51263, MGAS9429_Spy0594, 
MGAS2096_Spy0602, SPYOHK_01985, 
HKU488_01495, spyM18_0779, 
FE90_0223, B5D85_03105, 
AYM92_03010, DI45_06730, 
JMUB1235_0583, MGAS27061_0582, 
MGAS11027_0597, SD89_06900 
 spd1.2 
 
MGAS10394 (M6), JRS4 (M6), 
MGAS6180 (M28), M28PF1 (M28), 
STAB9014 (M28), MEW123 (M28), 
STAB10015 (M28) 
M6_Spy1195, SPYJRS4_1111, 
M28_Spy0968, ABO05_04560, 
VT08_04870, AWM59_04435, 
VU19_04860 
 spd1.3 Alab49 (M53), AP53 (M53) SPYALAB49_001168, AUQ45_1179 
spd3 
 
spd3.1 
 
SF370 (M1), MGAS5005 (M1), M1_476 
(M1), A20 (M1), 5448 (M1), AP1 (M1), 
NCTC8198 (M1), MGAS10270 (M2), 
MGAS10750 (M4), MEW427 (M4), 
Manfredo (M5), GUR (M11), HKU488 
(M12), HSC5 (M14), NZ131 (M49), 
Alab49 (M53), AP53 (M53), STAB13021 
(M66), STAB14018 (M75), STAB120304 
(M75), STAB090229 (M75), NGAS743 
(M87) 
 
SPy_1436, M5005_Spy1169, 
M1GAS476_1231, A20_1204, 
SP5448_03755, SPAP1_02890, 
ERS445054_01298, 
MGAS10270_Spy0852, 
MGAS10750_Spy0888, AWM58_03950, 
SpyM50534, B2G65_01915, 
HKU488_01108, L897_05810, 
Spy49_1455, SPYALAB49_001299, 
AUQ45_1308, AXK13_07360, 
AYM92_04205, B5D85_04335, 
B4W66_03985, DI45_04190 
 
spd3.2 M23ND (M23) FE90_0649 
 
spd3.3 MGAS8232 (M18) spyM18_1446 
 spd3.4 MGAS10394 (M6) M6_Spy1541 
spd4 spd4.1 MGAS315 (M3), SSI-1 (M3), STAB902 
(M3) 
SpyM3_1095, SPs0770, STAB902_04255 
 
spd4.2 Manfredo (M5) SpyM50691 
sdn sdn.1 MGAS315 (M3) SpyM3_1409 
 
sdn.2 SSI-1 (M3), STAB902 (M3) SPs0455, STAB902_02580 
 
sdn.3 MGAS10394 (M6) M6_Spy0067 
 
sdn.4 NGAS743 (M87), MGAS11027 (M89) DI45_06360, MGAS11027_0659 
 
sdn.5 STAB90229 (M75) B4W66_07530 
* Allele based on nucleotide sequence of the entire coding region. 454 
Figure Legends 455 
Figure 1. Phylogenetic analysis of streptococcal DNases. Full length coding regions of each identified 456 
and potential DNase gene were aligned using MUSCLE and a neighbour-joining tree created. Bootstrap 457 
values greater than 80% are shown on branches. Multiple alleles were compared for all prophage-458 
associated S. pyogenes DNase genes (red) but only single representative alleles for the chromosomal 459 
DNases spnA, spnB and s5nA are shown (blue). Alleles for Streptococcus dysgalactiae subsp equisimilis 460 
(SDSE) DNase genes were determined from five completed genomes; AC-2713 (NC_019042.1), 461 
GGS_124 (AP010935.1), RE378 (AP011114.1), 167 (AP012976.1), ATCC12394 (CP002215.1).  Alleles 462 
for Streptococcus zooepidemicus DNase genes (green) were determined from four completed 463 
genomes; H70 (FM204884.1), CY (CP006770.1), ATCC35246 (CP002904.1), MGCS10565 (CP001129.1). 464 
Alleles for Streptococcus equi DNase genes (green) were determined from two completed genomes; 465 
ATCC39806 (CP021972.1), 4047 (FM204883.1). Other DNase genes comprise endAsuis (SSU1009) and 466 
ssnA (SSU1760) from S. suis strain P1/7 (AM946016.1), swan (SSA_1750) from S. sanguinis SK36 467 
(CP000387.1), spnA (K710_1281) from S. iniae SF1 (CP005941.1), spd1 (STRPO_1639) from S. porcinus 468 
str. Jelinkova 176 (AEUU02000001.1), group B Streptococcus (GBS) nuc (gbs0661) from S. agalactiae 469 
NEM316 (AL732656.1).  470 
Figure 2. Streptococcal DNases can degrade neutrophil extracellular traps (NETs). NETs are 471 
composed primarily of DNA (blue strands) associated with histones and other antibacterial factors 472 
(yellow circles). Bacteria can be ensnared in the DNA traps and killed by the associated factors (left-473 
hand figure). Streptococcal secreted and cell-anchored DNases (indicated as scissors) degrade NETs, 474 
allowing the bacteria to escape prevent killing (Right-hand figure).   475 
 476 
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